Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor
about
Signal peptidase complex subunit 1 participates in the assembly of hepatitis C virus through an interaction with E2 and NS2Hepatitis C virus differentially modulates activation of forkhead transcription factors and insulin-induced metabolic gene expressionSystems virology identifies a mitochondrial fatty acid oxidation enzyme, dodecenoyl coenzyme A delta isomerase, required for hepatitis C virus replication and likely pathogenesisChaperones in hepatitis C virus infectionHost-Targeting Agents to Prevent and Cure Hepatitis C Virus InfectionGenetic Diversity Underlying the Envelope Glycoproteins of Hepatitis C Virus: Structural and Functional Consequences and the Implications for Vaccine DesignImpact of lipids and lipoproteins on hepatitis C virus infection and virus neutralizationMurine models of hepatitis C: what can we look forward to?The hepatitis C virus glycan shield and evasion of the humoral immune responseMolecular determinants and dynamics of hepatitis C virus secretionMouse-Specific Residues of Claudin-1 Limit Hepatitis C Virus Genotype 2a Infection in a Human Hepatocyte Cell LineA novel small molecule inhibitor of hepatitis C virus entryHepatitis C virus cell entry: a target for novel antiviral strategies to address limitations of direct acting antivirals.Human subtilase SKI-1/S1P is a master regulator of the HCV Lifecycle and a potential host cell target for developing indirect-acting antiviral agentsGenes and hepatitis C: susceptibility, fibrosis progression and response to treatment.The missing pieces of the HCV entry puzzle.Adaptation of hepatitis C virus to mouse CD81 permits infection of mouse cells in the absence of human entry factors.Lipoprotein lipase inhibits hepatitis C virus (HCV) infection by blocking virus cell entryVisualizing hepatitis C virus infection in humanized mice.The C-terminal alpha-helix domain of apolipoprotein E is required for interaction with nonstructural protein 5A and assembly of hepatitis C virus.Infectivity of hepatitis C virus is influenced by association with apolipoprotein E isoforms.Species-specific regions of occludin required by hepatitis C virus for cell entry.MAP-kinase regulated cytosolic phospholipase A2 activity is essential for production of infectious hepatitis C virus particles.Biochemical and morphological properties of hepatitis C virus particles and determination of their lipidome.Temporal analysis of hepatitis C virus cell entry with occludin directed blocking antibodies.Functional characterization of nuclear localization and export signals in hepatitis C virus proteins and their role in the membranous web.Amphipathic α-helices in apolipoproteins are crucial to the formation of infectious hepatitis C virus particlesIL-1β production through the NLRP3 inflammasome by hepatic macrophages links hepatitis C virus infection with liver inflammation and diseaseProtein kinase D negatively regulates hepatitis C virus secretion through phosphorylation of oxysterol-binding protein and ceramide transfer proteinProduction of hepatitis C virus lacking the envelope-encoding genes for single-cycle infection by providing homologous envelope proteins or vesicular stomatitis virus glycoproteins in trans.Hepatitis C virus life cycle and lipid metabolismIL28B gene polymorphisms and US liver fatty changes in patients who spontaneously cleared hepatitis C virus infectionGP73 is upregulated by hepatitis C virus (HCV) infection and enhances HCV secretion.Syndecan 4 is involved in mediating HCV entry through interaction with lipoviral particle-associated apolipoprotein EHepatitis C virus E1 envelope glycoprotein interacts with apolipoproteins in facilitating entry into hepatocytes.Lipid metabolism and HCV infectionProduction and characterization of high-titer serum-free cell culture grown hepatitis C virus particles of genotype 1-6.Effects of hypolipidemic agent nordihydroguaiaretic acid on lipid droplets and hepatitis C virus.Detergent-resistant membrane association of NS2 and E2 during hepatitis C virus replicationMorphogenesis of infectious hepatitis C virus particles
P2860
Q24322876-B1672B35-486A-4F0E-B311-85C854BBCCB2Q24606745-173C2544-232E-460F-9721-4D6382B110D5Q24631218-939989C4-E5C2-43FF-884E-6C254E61759BQ26771251-C8D945E7-CDEE-433A-9EB5-B8492AC50D07Q26779128-AF7FF93F-D96E-4C81-8E7E-6B6FFA566A23Q26801759-710D9043-7AF4-4162-9825-3D352653C2E1Q26864485-B2F575AA-C0CE-4050-A131-D1D8B98CC1C2Q26991875-5C290198-B5E9-47E3-ADDB-FCBFABB0AE31Q27023390-290D23E4-9216-4677-B991-D68BD4A1AE9FQ27347838-232E4745-D951-4F1D-B2D1-B69F444F596DQ27490526-92337046-3F03-44FC-A7BD-83E26BED6A7FQ28475468-DFE43FE1-EE2F-4E0A-97D8-13303296BCE7Q30386551-17831AFA-DBDC-422D-9332-189F38FD2462Q31045004-1A394D4C-9CA3-4EA1-84C2-0F9074B5F1FEQ33350754-3F20BA16-98B1-43EF-B91F-B94F89AB03F7Q33360674-46926A51-ADDA-4E3A-941A-355D627B97A0Q33628805-FBD3DCF6-424D-4614-9315-A9F9A7E8C0DCQ34062532-398F719D-7B8E-426A-9566-46915953BFB6Q34175159-5E817CED-3065-4A4E-821D-F6B18D8AA5C6Q34190545-C638FA52-92ED-4D02-AD78-66D11528E650Q34295937-FF0AD716-F902-4925-B7FF-A6FFA581B667Q34296017-796322D7-1AD6-47D3-931D-49D8E3BCFBAFQ34387277-791EBF79-4C6E-4F26-AA64-14C379E64646Q34509568-CC135EFF-3FCA-48AD-9E10-9894AFA0BBEDQ34649662-47B99DCB-6130-4F82-85A4-94EDEB8AA260Q34653969-B1C74789-5385-48F3-BFAB-3A25A36FCFA4Q34682186-C7436733-F6A7-4F36-BDA1-FD877039C3E1Q34697945-D74AC1C6-580E-400F-A37B-D5545001D11CQ34719596-226A2AAE-F10B-40F5-B8EE-8D0572887D66Q34741763-3A591FD8-2C4F-4F0D-A13C-C5AA6065A658Q34792436-6082CB9B-214E-44F2-9BC0-04F49D0255D4Q34923937-A71E7D96-117D-4D90-9C46-4B93E06944F3Q35114636-168EC6F1-862E-489B-A3BF-49EFCE218634Q35153978-8C0BB6DB-EE32-46A1-A077-670DE7879229Q35249163-6A323CB5-E4AE-4A59-BFA9-E4EB10DDBD10Q35275932-0D74DFF9-030D-41CB-92A7-E0FCA169B51CQ35557533-C76C60F8-43D5-4AF5-8A12-B18261575F09Q35609581-0381DEC0-5B44-4AA1-B944-6AC7D89F21BEQ35641053-E4471A2A-F113-4386-ACED-EB895B63378BQ35740670-2D76C95E-5221-4858-BE08-250702EF9B59
P2860
Apolipoprotein E on hepatitis C virion facilitates infection through interaction with low-density lipoprotein receptor
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@ast
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@en
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@nl
type
label
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@ast
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@en
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@nl
prefLabel
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@ast
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@en
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@nl
P2860
P3181
P1433
P1476
Apolipoprotein E on hepatitis ...... w-density lipoprotein receptor
@en
P2093
P2860
P304
P3181
P356
10.1016/J.VIROL.2009.08.037
P407
P577
2009-11-10T00:00:00Z